By contrast, data from the CHOPIN study suggested that the levels of cTnI measured in patients presenting with chest pain in the emergency department did not predict neither mortality, nor MACEs (defined as ED visit or hospitalization for AMI, unstable angina, HF, reinfarction, stroke) during the 180 days of follow-up. The gene discussed is TNNI3; the disease is stroke disorder.